Avi Albert
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (14)
Year:
2026
Objective: To (1) retrospectively apply the updated American Congress of Rehabilitation Medicine (ACRM) mild traumatic brain injury (mTBI) criteria to a cohort of high school athletes previously diagnosed with sport-related concussion (SRC) using prior clinical definitions, and (2) compare demographics, medical history, and recovery outcomes between those who met the full mTBI criteria versus those classified as suspected mTBI. Setting: Outpatient Specialty Concussion Clinic. Participants: In total, 181 concussed athletes aged 14 to 18 years were presented to clinic within 72 hours of injury. All were diagnosed with SRC by a certified athletic trainer or physician using the Concussion in Sport Group definition, which defines SRC as any traumatic blow to the head/body causing neurologic symptoms. Design: Retrospective cohort study. Main Measures: Participants were classified as having a full or suspected mTBI based on the ACRM 2023 criteria. Full mTBIs required: (1) a plausible mechanism and either (2a) a clinical sign (eg, amnesia, loss of consciousness), or (2b) at least 2 symptoms plus a clinical examination finding. Suspected mTBIs had a plausible mechanism and at least 2 symptoms or at least 2 examination findings. Groups were compared across demographics, medical history, and recovery metrics (return-to-learn, symptom resolution, return-to-play). Results: Of the 181 patients (mean age 16.3 ± 1.3 years; 35.9% female), 114 (63.0%) met the definition for a full mTBI, whereas 67 (37.0%) had a suspected mTBI. Significant differences included higher rates of family migraine history (24.8% vs 7.7%, P = .019) and on-field evaluations (50.4% vs 38.5%, P .05). Conclusion: Among high school athletes with SRC, most met the updated full ACRM mTBI criteria, with the rest meeting the suspected mTBI criteria. Results suggest high sensitivity for the ACRM definition for diverse concussion presentations.
Year:
2025
BACKGROUND AND OBJECTIVES: Brachial plexus injury (BPI) is a disabling condition, with elbow flexion restoration as a key surgical goal. The Oberlin procedure involves either single fascicular transfer (SFT) using an ulnar nerve fascicle or double fascicular transfer (DFT), which adds a median nerve fascicle. This study compares SFT and DFT for improving elbow flexion strength at short-term and long-term time postoperative dates. METHODS: This retrospective single-center cohort study included patients with BPI who underwent elbow flexion neurotization using SFT or DFT between February 2017 and March 2022. Clinical and perioperative data were collected, including injury type and severity, root involvement, electrodiagnostic findings, and timing. Elbow flexion strength was evaluated using the Medical Research Council (MRC) scale preoperatively and at follow-up visits (6 months, ≤1 year, ≤2 years, and >2 years). RESULTS: Of 39 patients, 22 (56.4%) underwent SFT and 17 (43.6%) underwent DFT. SFT patients were significantly younger ( P = .029). DFT was more common in isolated upper trunk injuries (82.4%), whereas SFT was preferred in cases with multiple cervical root involvement ( P = .068). Overall, 82% achieved MRC ≥3 ( P = .037), including 91% in SFT and 71% in DFT groups ( P = .231). SFT patients showed earlier improvement by 6 months, whereas DFT patients showed significant gains from ≤1 year onward. On multivariate analysis, better outcomes were associated with higher preoperative MRC (M1: odds ratio [OR] = 5.91, P = .162; M2: OR = 174.10, P = .031) and younger age (OR = 0.91, P = .018). Procedure type was not significantly associated with final MRC (OR = 4.28, P = .318). CONCLUSION: Nerve transfer effectively restores elbow flexion after upper BPI. SFT and DFT both offer comparable MRC improvement to enhance patient outcomes after BPI.
Year:
2025
OBJECTIVE Limited literature exists on predictors for delayed presentation to a specialty concussion clinic following sport-related concussions (SRCs). The current study aimed to 1) describe demographics, injury characteristics, and recovery timelines for athletes presenting to a concussion clinic at least 30 days after SRC; and 2) identify predictors of delayed presentation ≥ 30 days postinjury. METHODS The current retrospective cohort study examined 14- to 18-year-old athletes who sustained SRCs from November 2017 to April 2022 and presented to a specialty sports concussion clinic. Presentation time was categorized as < 30 days or ≥ 30 days postinjury. Univariate analyses included chi-square, Mann-Whitney U-, and t-tests. Multivariable logistic regression was performed controlling for age, sex, on-field evaluation, distance from the clinic, psychiatric conditions, migraines, and family history of psychiatric conditions/migraines. RESULTS Of 923 athletes (mean age 16.2 ± 1.2, 66.2% male), 872 (94.5%) presented within 30 days of their concussion, and 51 (5.5%) presented ≥ 30 days after injury. Delayed presenters (≥ 30 days) lived farther away (U = 29,941.5, p < 0.001), had higher proportions of psychiatric history (χ 2 = 17.23, p < 0.001), family migraine history (χ 2 = 17.23, p < 0.001), family psychiatric history (χ 2 = 26.52, p < 0.001), prior healthcare visits to nonspecialty sites (χ 2 = 6.44, p = 0.012), and had lower rates of on-field evaluations (χ 2 = 14.28, p < 0.001). In the multivariable logistic regression predicting delayed presentation, significant predictors included psychiatric history (OR 1.40, p = 0.022), family migraine history (OR 1.39, p = 0.007), and absence of on-field evaluation (OR 0.23, p < 0.001). Not surprisingly, late presenters had longer times to symptom resolution (median 54.0 vs 15.5 days, U = 13,470.5, p < 0.001) and return to play (median 55.5 vs 20.0 days, U = 14,822.0, p < 0.001). CONCLUSIONS In high school–aged athletes with SRCs, psychiatric history, family history of migraine, and absence of on-field evaluation were predictors of delayed presentation to a specialty concussion clinic presentation. These findings highlight opportunities to improve timely access to a dedicated sports concussion center, which may improve outcomes through early intervention.
Year:
2025
Year:
2025
Background/Objectives: Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive malignancies with a challenging prognosis, especially for patients with Neurofibromatosis type 1 (NF1). Their low incidence necessitates comprehensive studies to investigate the survival outcome. Methods: We conducted a systematic review and meta-analysis, including data from 16 studies and 4265 patients, to explore surgical outcomes and survival rates, focusing on time-related outcomes, including overall survival (OS), progression-free survival (PFS), and recurrence rate. Results: The analysis revealed that the OS rate was 86% [95% CI: 75–97%] at 1 year, decreasing to 60% [95% CI: 45–75%] at 3 years, and further declining to 47% [95% CI: 35–58%] by 5 years. For PFS, the 1-year rate was 61% [95% CI: 25–98%], which remained similar at 62% [95% CI: 35–89%] for 3 and 5 years. In NF1-associated MPNSTs, the 1-year OS was relatively high at 93% [95% CI: 83–100%], but it dropped to 68% [95% CI: 53–84%] at 3 years and further to 50% [95% CI: 31–68%] at 5 years. Additionally, the hazard ratio indicated a 38% lower survival rate in NF1 patients than those with sporadic MPNSTs when data were presented in the same study. Recurrence rates were high, with 56% of patients experiencing a relapse, primarily as local recurrences (70.6%). Mortality was significant, with over 50% of patients dying within an average follow-up period of 33.45 months. Conclusions: MPNSTs, particularly in NF1 patients, are associated with poor prognosis and high recurrence rates. These results underline the necessity of targeted therapeutic strategies and improved programs for screening, mainly through a multidisciplinary approach to optimize management.
Year:
2025
Objective While most concussions present with common symptoms, some patients experience atypical manifestations that challenge diagnosis and management. This review synthesizes studies reporting atypical post-concussive symptoms with individual patient-level data, focusing on functional neurologic disorders. Methods A systematic review was conducted across PubMed, EMBASE, and Cochrane Library databases (01/2000–08/2023). Inclusion criteria were: (1) study participants with concussion or mild traumatic brain injury, (2) trauma and/or sport-related injury, and (3) atypical symptoms without observable imaging findings. Atypical symptoms were defined as neurological symptoms not fully explained by traditional neuroanatomical or neuropathological correlates. Four independent reviewers screened titles, abstracts, and full texts. Data extraction included patient demographics, symptom characteristics, diagnostic methods, treatments, and outcomes. Results Of the 4725 screened studies, 15 met inclusion criteria (2000–2022). Studies originated from five countries, with 8 (53.3%) from the United States. All studies were case reports (n = 12, 80.0%) or case series (n = 3, 20.0%). The review identified atypical symptoms across five domains: speech disorders (n = 6 studies, primarily new-onset stuttering), psychiatric alterations (n = 4 studies, including dissociative symptoms, Ganser syndrome, and psychotic features), visual changes (n = 1 study), hearing/vestibular disturbances (n = 2 studies), and gait abnormalities (n = 2 studies). Recovery patterns varied widely, ranging from complete resolution within weeks to persistent symptoms over several years. Conclusion While most patients eventually improved with targeted interventions like speech therapy, psychiatric care, or physical therapy, recovery trajectories varied significantly. Larger prospective studies are needed to determine true incidence rates and establish evidence-based treatment protocols.
Year:
2025
Objectives: This study aims to identify clinical characteristics and biomarkers influencing survival outcomes in colorectal cancer (CRC) patients with spinal metastases. Methods: We conducted a retrospective cohort study involving 27 patients treated for CRC-derived spinal metastases at Johns Hopkins Hospital. Data on demographics, biomarker profiles of the primary colorectal tumor site, surgical outcomes, and survival were collected. Neurological function was assessed pre- and postoperatively using Frankel scores. Survival outcomes included overall survival (OS) and post-metastasis survival. Results: The median age of the patients was 58 years, with 63% being women. The sacral spine was the most frequently involved site (59.3%), followed by the thoracic and lumbar regions. Most patients (89%) already had extraspinal metastases, predominantly in the lungs. Biomarker analysis showed microsatellite stability in 63% of patients and CDX2 (Caudal-type homeobox 2) expression in 37%. Laminectomy was performed in 85% of cases and sacrectomy in 55.6%, leading to postoperative improvements in ambulatory function and neurological status. The main indications included local recurrence of the tumor and neurological deficits attributed to the impinging tumor. The median overall survival was 4.9 years, while the median post-metastasis survival was 3.0 years. Univariable analysis revealed that CK20 expression (p = 0.041) and spinal tumor recurrence (p = 0.045) were significantly associated with shorter post-metastasis survival. Conclusions: This study highlights the prognostic importance of CK20 expression and spinal tumor recurrence in CRC patients diagnosed with spinal metastases. Surgical intervention significantly improved neurological outcomes, enhancing patient quality of life. Further research with larger cohorts is needed to confirm these findings and optimize treatment strategies for this challenging patient population.
Year:
2025
OBJECTIVE Schwannomatosis is a rare genetic predisposition to develop multiple nonintradermal schwannomas affecting the spine and peripheral nerves, excluding vestibular schwannomas. Schwannomatosis-associated schwannomas can present with pain or motor deficits, prompting resection. In this study, the authors reported the clinical characteristics, surgical interventions, and postoperative outcomes of patients with schwannomatosis-related schwannomas treated with resection. METHODS This was a retrospective cohort study of adult patients with schwannomatosis who had undergone resection of a symptomatic peripheral or spinal schwannoma at the authors’ institution from September 2003 to June 2023. Data were extracted from electronic health records and provider notes. RESULTS A cohort of 85 patients (57.6% women) had a mean follow-up of 68.4 ± 58.2 months after surgery. The mean age at the time of surgery was 44.6 ± 16.5 years. Pain was the most common presenting symptom (94.1%), followed by motor weakness (36.4%) and sensory deficits (32.9%). Just under two-thirds of the patients (64.7%) had undergone prior surgery for schwannoma, 20 (36.4%) of whom had a prior resection in the same exact location. Gross-total resection (GTR) was achieved in 88.2% of cases and en bloc resection in 69.4%. There were significant improvements in pain, motor weakness, and sensory deficits at the last postoperative follow-up visit. There was local tumor recurrence in 14 patients (16.5%), and the overall mortality rate was 4.7%. Univariate and multivariate analyses identified GTR as the strongest predictor of a decreased risk of local recurrence (HR 0.09, 95% CI 0.02−0.48, p = 0.005). CONCLUSIONS Patients with schwannomatosis commonly presented with neurological symptoms of pain, sensory deficits, or motor weakness associated with their schwannomas. Resection significantly improved their preoperative symptoms, and GTR was associated with a decreased risk of local recurrence.
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Collaborators (2)
Nicholas Theodore
Professor and Chairman
Johns Hopkins University School of Medicine
Allan Belzberg
Professor of Neurosurgery
Johns Hopkins University
Make your next move.
Prepare your application
Review drafts before you send them.